SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
157 hedge funds and large institutions have $522M invested in SANGAMO THERAPEUTICS INC in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 45 reducing their positions, and 21 closing their positions.
2,450% more call options, than puts
Call options by funds: $138M | Put options by funds: $5.39M
13% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 45
10% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 21
1% more funds holding
Funds holding: 156 → 157 (+1)
30% less capital invested
Capital invested by funds: $747M → $522M (-$225M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$8.22M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$5.83M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.39M |
| 4 |
Millennium Management
New York
|
+$4.74M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$4.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$20.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$11.5M |
| 3 |
TCM
TimesSquare Capital Management
New York
|
-$10.6M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$5.38M |
| 5 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
-$5.25M |
SGMO Hedge Fund Activity: Q3 2014 in Review
157 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2014, worth a combined $522M — down 30% from $747M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new SGMO positions and 21 closed out — a net gain of 2 holders — while 51 added to existing stakes and 45 trimmed.
The largest buyer was Tekla Capital Management, adding an estimated $8.22M. The largest seller was RA Capital Management, cutting an estimated $20.5M.
- 157 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2014, up from 156 in Q2 2014.
- Funds reported $522M of SANGAMO THERAPEUTICS INC stock for Q3 2014, down 30% quarter-over-quarter.
- 23 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2014 and 21 closed out, a net change of +2 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q3 2014 was Tekla Capital Management, an estimated $8.22M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q3 2014 was RA Capital Management, an estimated $20.5M sold.
Based on aggregated 13F filings for Q3 2014.